Mantle cell lymphomas lack expression of p27kip1, a cyclin-dependent kinase inhibitor

被引:97
|
作者
Quintanilla-Martinez, L
Thieblemont, C
Fend, F
Kumar, S
Pinyol, M
Campo, E
Jaffe, ES
Raffeld, M
机构
[1] NCI, Hematopathol Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Barcelona, Hosp Clin Prov, Barcelona, Spain
来源
AMERICAN JOURNAL OF PATHOLOGY | 1998年 / 153卷 / 01期
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0002-9440(10)65558-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
p27(Kip1) is a cyclin-dependent kinase inhibitor that regulates the decision to enter S phase or withdraw from the cell cycle. In resting cells, the level of p27(Kip1) provides an inhibitory threshold above which G1 cyclin D/E/cyclin-dependent kinases accumulate before activation; however, in cycling cells, p27(Kip1) protein is sequestered by high levels of active cyclin D/cyclin-dependent kinase 4 complexes. As a group, the cyclin-dependent kinase inhibitors have been proposed to act as tumor suppressor genes, and several members have been implicated in the pathogenesis of a variety of human cancers. We examined p27(Kip1) expression in 116 non-Hodgkin's lymphomas including 50 cases of MCL (40 typical and 10 blastic variants), 21 follicular lymphomas, 20 diffuse large B-cell lymphomas, 16 chronic lymphocytic leukemias, 8 marginal zone B-cell lymphomas, and 1 splenic marginal zone lymphoma, and correlated its expression with that of the proliferation marker Ki67 (MiB1) and with p53. p27(Kip1) gene structure was analyzed by Southern blot in the group of MCLs, In all cases of non-Hodgkin's lymphoma other than MCL, p27(Kip1) expression was inversely related to the proliferation index as measured by Ki67, In contrast, in typical MCL, p27(Kip1) expression was negative in 35 of 40 (88%) cases, irrespective of the proliferative rate (median 15%; range 2 to 90%). Paradoxically, in the blastic variant of MCL, 8 of 10 (80%) cases showed expression of p27(Kip1), despite a high proliferation rate (median 60%; range 52 to 100%). However, the staining in most of the cases was less intense than in the reactive T lymphocytes, Deletions of p27(Kip1) gene were not found in any of the 25 cases examined. p53 expression was found in 15 of 50 cases of MCL: 7 of 10 (70%) in the blastic variant and 8 of 40 (20%) in the typical MCL (70% vs. 20%, P < 0.0045), These results demonstrate that MCLs, in contrast to other non-Hodgkin's lymphomas and normal lymphoid tissue, fail to correlate p27(Kip1) expression with the proliferation rate. This peculiar uncoupling of p27(Kip1) protein expression from the proliferation rate may be related to the high levels of cyclin D1 expressed in MCL and is likely to have profound effects on cell cycle regulation and contribute to the pathogenesis of MCL.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 50 条
  • [21] The Cyclin-Dependent Kinase Inhibitor p27Kip1 is a Positive Regulator of Schwann Cell Differentiation In Vitro
    Li, Honghui
    Yang, Huiguang
    Liu, Yonghua
    Huan, Weipeng
    Zhang, Shuangwei
    Wu, Gang
    Lu, Qiuhui
    Wang, Qiuhong
    Wang, Youhua
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (02) : 277 - 283
  • [22] Expression of the cyclin-dependent kinase inhibitor p27(kip) in keratoacanthoma
    Hu, W
    Cook, T
    Oh, C
    Penneys, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 583 - 583
  • [23] Low expression of p27Kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma
    Kawauchi, S
    Goto, Y
    Liu, XP
    Furuya, T
    Oga, A
    Oda, Y
    Tsuneyoshi, M
    Ihara, K
    Sasaki, K
    CANCER, 2001, 91 (05) : 1005 - 1012
  • [24] Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1:: a strategy for breast cancer gene therapy
    Rakkar, ANS
    Li, ZW
    Katayose, Y
    Kim, M
    Cowan, KH
    Seth, P
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (23) : 1836 - 1838
  • [25] PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27Kip1
    Perez-Luna, Maria
    Aguasca, Marta
    Perearnau, Anna
    Serratosa, Joan
    Martinez-Balbas, Marian
    Jesus Pujol, Maria
    Bachs, Oriol
    NUCLEIC ACIDS RESEARCH, 2012, 40 (14) : 6520 - 6533
  • [26] P27kip1:: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
    Lloyd, RV
    Erickson, LA
    Jin, L
    Kulig, E
    Qian, X
    Cheville, JC
    Scheithauer, BW
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02): : 313 - 323
  • [27] Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development
    Koh, KN
    Kang, MJ
    Frith-Terhune, A
    Park, SK
    Kim, I
    Lee, CO
    Koh, GY
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (03) : 463 - 474
  • [28] The cyclin-dependent kinase inhibitor, p27kip1, has no correlation with the malignant potential of GIST
    Shirin, Haim
    Kravtsov, Vladimir
    Shahmurov, Mark
    Shabat, Vered Sehayek
    Krinshpon, Ivgeni
    Alin, Avi
    Avinoach, Ilana
    Avni, Yona
    DIGESTION, 2007, 75 (01) : 4 - 9
  • [29] Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer
    Serth, J
    Kuczyk, M
    Machtens, S
    Bokemeyer, C
    Herrmann, R
    Hartmann, J
    Knüchel, R
    Jonas, U
    ONCOLOGY REPORTS, 1999, 6 (01) : 229 - 233
  • [30] Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma
    Kudo, V
    Takata, T
    Yasui, W
    Ogawa, I
    Miyauchi, M
    Takekoshi, T
    Tahara, E
    Nikai, H
    CANCER, 1998, 83 (12) : 2447 - 2455